Skip to main content
Top
Published in: Abdominal Radiology 9/2016

Open Access 01-09-2016

Single-session alcohol sclerotherapy of symptomatic liver cysts using 10–20 min of ethanol exposure: no recurrence at 2–16 years of follow-up

Authors: Trond Bjerke Larssen, Asgaut Viste, Arild Horn, Ingfrid Salvesen Haldorsen, Ansgar Espeland

Published in: Abdominal Radiology | Issue 9/2016

Login to get access

Abstract

Purpose

To assess long-term results after single-session alcohol sclerotherapy of symptomatic benign liver cysts performed with maximum 20 min of exposure to alcohol.

Methods

We included 47 patients aged 32–88 years (42 women, 5 men) with 51 benign non-parasitic liver cysts that were exposed to ethanol for 7–20 min in a single sclerotherapy session and were followed for at least 24 months. Each cyst was emptied before injecting ethanol (10% of cyst volume, but maximum 100 mL) into it. The patient rotated from side to side to facilitate contact between ethanol and the whole cyst wall. Pre-treatment cyst volume was defined as the volume of aspirated cyst fluid after complete emptying of the cyst. Follow-up cyst volume was estimated based on computed tomography images.

Results

Cyst volumes were 30–4900 (median 520) mL at pre-treatment and 0–230 (median 1) mL at 24–193 (median 56) months follow-up, a reduction of 83–100% (median 99.7%). No cyst required repeated treatment during the follow-up. Median volume reduction was 99.7% at median 49 months of follow-up for 35 cysts exposed to ethanol for 7–10 min vs. 99.6% at median 75 months of follow-up for 16 cysts exposed for 20 min (p = 0.83, Mann–Whitney test). Ethanol intoxication occurred in one patient. There were no other complications except for pain.

Conclusion

Long-term results of single-session alcohol sclerotherapy performed with maximum 20 min of exposure to ethanol were satisfactory with no sign of recurrence of cyst fluid.
Literature
2.
go back to reference Tikkakoski T, Makela JT, Leinonen S, et al. (1996) Treatment of symptomatic congenital hepatic cysts with single-session percutaneous drainage and ethanol sclerosis: technique and outcome. J Vasc Intervent Radiol 7:235–239CrossRef Tikkakoski T, Makela JT, Leinonen S, et al. (1996) Treatment of symptomatic congenital hepatic cysts with single-session percutaneous drainage and ethanol sclerosis: technique and outcome. J Vasc Intervent Radiol 7:235–239CrossRef
6.
go back to reference Kairaluoma MI, Leinonen A, Stahlberg M, et al. (1989) Percutaneous aspiration and alcohol sclerotherapy for symptomatic hepatic cysts. An alternative to surgical intervention. Ann Surg 210:208–215CrossRefPubMedPubMedCentral Kairaluoma MI, Leinonen A, Stahlberg M, et al. (1989) Percutaneous aspiration and alcohol sclerotherapy for symptomatic hepatic cysts. An alternative to surgical intervention. Ann Surg 210:208–215CrossRefPubMedPubMedCentral
8.
go back to reference Larssen TB, Rosendahl K, Horn A, Jensen DK, Rorvik J (2003) Single-session alcohol sclerotherapy in symptomatic benign hepatic cysts performed with a time of exposure to alcohol of 10 min: initial results. Eur Radiol 13:2627–2632. doi:10.1007/s00330-003-1923-7 CrossRefPubMed Larssen TB, Rosendahl K, Horn A, Jensen DK, Rorvik J (2003) Single-session alcohol sclerotherapy in symptomatic benign hepatic cysts performed with a time of exposure to alcohol of 10 min: initial results. Eur Radiol 13:2627–2632. doi:10.​1007/​s00330-003-1923-7 CrossRefPubMed
10.
go back to reference Moorthy K, Mihssin N, Houghton PW (2001) The management of simple hepatic cysts: sclerotherapy or laparoscopic fenestration. Ann R Coll Surg Engl 83:409–414PubMedPubMedCentral Moorthy K, Mihssin N, Houghton PW (2001) The management of simple hepatic cysts: sclerotherapy or laparoscopic fenestration. Ann R Coll Surg Engl 83:409–414PubMedPubMedCentral
12.
go back to reference Feng Y-H, Qian L-X, Gong H-M, et al. (2012) Sclerotherapy of simple hepatic cysts by repeated aspiration and alcohol instillation. Turk J Gastroenterol 23:359–365CrossRef Feng Y-H, Qian L-X, Gong H-M, et al. (2012) Sclerotherapy of simple hepatic cysts by repeated aspiration and alcohol instillation. Turk J Gastroenterol 23:359–365CrossRef
13.
go back to reference Benzimra J, Ronot M, Fuks D, et al. (2014) Hepatic cysts treated with percutaneous ethanol sclerotherapy: time to extend the indications to haemorrhagic cysts and polycystic liver disease. Eur Radiol 24:1030–1038. doi:10.1007/s00330-014-3117-x CrossRefPubMed Benzimra J, Ronot M, Fuks D, et al. (2014) Hepatic cysts treated with percutaneous ethanol sclerotherapy: time to extend the indications to haemorrhagic cysts and polycystic liver disease. Eur Radiol 24:1030–1038. doi:10.​1007/​s00330-014-3117-x CrossRefPubMed
19.
go back to reference Valette PJ, Chataing L, Partensky C, Paliard P (1987) Treatment of hepatic polycystosis by intracystic injection of alcohol. Gastroenterol Clin Biol 11:898–900PubMed Valette PJ, Chataing L, Partensky C, Paliard P (1987) Treatment of hepatic polycystosis by intracystic injection of alcohol. Gastroenterol Clin Biol 11:898–900PubMed
20.
go back to reference Zerem E, Imamovic G, Omerovic S (2008) Percutaneous treatment of symptomatic non-parasitic benign liver cysts: single-session alcohol sclerotherapy versus prolonged catheter drainage with negative pressure. Eur Radiol 18:400–406. doi:10.1007/s00330-007-0760-5 CrossRefPubMed Zerem E, Imamovic G, Omerovic S (2008) Percutaneous treatment of symptomatic non-parasitic benign liver cysts: single-session alcohol sclerotherapy versus prolonged catheter drainage with negative pressure. Eur Radiol 18:400–406. doi:10.​1007/​s00330-007-0760-5 CrossRefPubMed
21.
go back to reference Simonetti G, Profili S, Sergiacomi GL, Meloni GB, Orlacchio A (1993) Percutaneous treatment of hepatic cysts by aspiration and sclerotherapy. Cardiovasc Intervent Radiol 16:81–84CrossRefPubMed Simonetti G, Profili S, Sergiacomi GL, Meloni GB, Orlacchio A (1993) Percutaneous treatment of hepatic cysts by aspiration and sclerotherapy. Cardiovasc Intervent Radiol 16:81–84CrossRefPubMed
22.
go back to reference Akhan O, Islim F, Balci S, et al. (2015) Percutaneous treatment of simple hepatic cysts: the long term results of PAIR and catheterization techniques as single-session procedures. Cardiovasc Intervent Radiol . doi:10.1007/s00270-015-1283-0 Akhan O, Islim F, Balci S, et al. (2015) Percutaneous treatment of simple hepatic cysts: the long term results of PAIR and catheterization techniques as single-session procedures. Cardiovasc Intervent Radiol . doi:10.​1007/​s00270-015-1283-0
23.
go back to reference Jang SY, Park SY, Tak WY, Kweon YO, Ryeom H (2016) Long-term follow-up of large symptomatic hepatic cysts treated by percutaneous ethanol sclerotherapy. Acta Radiol. doi:10.1177/0284185115626476 Jang SY, Park SY, Tak WY, Kweon YO, Ryeom H (2016) Long-term follow-up of large symptomatic hepatic cysts treated by percutaneous ethanol sclerotherapy. Acta Radiol. doi:10.​1177/​0284185115626476​
24.
go back to reference Farges O, Menu Y, Benhamou J-P (2000) Non-parasitic cystic diseases of the liver and intrahepatic biliary tree. In: Blomgart L, Fong Y (eds) Surgery of the liver and biliary tract. London: W. B. Saunders Company LTD, pp 1245–1260 Farges O, Menu Y, Benhamou J-P (2000) Non-parasitic cystic diseases of the liver and intrahepatic biliary tree. In: Blomgart L, Fong Y (eds) Surgery of the liver and biliary tract. London: W. B. Saunders Company LTD, pp 1245–1260
25.
go back to reference Nagorney D (2000) Surgical management of cystic disease of the liver. In: Blumgart L, Fong Y (eds) Surgery of the liver and biliary tract. London: W. B. Saunders Company LTD, pp 1261–1276 Nagorney D (2000) Surgical management of cystic disease of the liver. In: Blumgart L, Fong Y (eds) Surgery of the liver and biliary tract. London: W. B. Saunders Company LTD, pp 1261–1276
27.
go back to reference Tapani E, Taavitsainen M, Lindros K, Vehmas T, Lehtonen E (1996) Toxicity of ethanol in low concentrations. Experimental evaluation in cell culture. Acta Radiol 37:923–926CrossRefPubMed Tapani E, Taavitsainen M, Lindros K, Vehmas T, Lehtonen E (1996) Toxicity of ethanol in low concentrations. Experimental evaluation in cell culture. Acta Radiol 37:923–926CrossRefPubMed
28.
go back to reference Larssen TB, Rorvik J, Horn A, et al. (2004) Biochemical and cytologic analysis of cystic contents in benign non-parasitic symptomatic hepatic cysts before and after ethanol sclerotherapy. Acta Radiol 45:504–509. doi:10.1080/02841850410006588 CrossRefPubMed Larssen TB, Rorvik J, Horn A, et al. (2004) Biochemical and cytologic analysis of cystic contents in benign non-parasitic symptomatic hepatic cysts before and after ethanol sclerotherapy. Acta Radiol 45:504–509. doi:10.​1080/​0284185041000658​8 CrossRefPubMed
29.
go back to reference Campbell S, Wladimiroff JW, Dewhurst CJ (1973) The antenatal measurement of fetal urine production. J Obstet Gynaecol Br Commonw 80:680–686CrossRefPubMed Campbell S, Wladimiroff JW, Dewhurst CJ (1973) The antenatal measurement of fetal urine production. J Obstet Gynaecol Br Commonw 80:680–686CrossRefPubMed
Metadata
Title
Single-session alcohol sclerotherapy of symptomatic liver cysts using 10–20 min of ethanol exposure: no recurrence at 2–16 years of follow-up
Authors
Trond Bjerke Larssen
Asgaut Viste
Arild Horn
Ingfrid Salvesen Haldorsen
Ansgar Espeland
Publication date
01-09-2016
Publisher
Springer US
Published in
Abdominal Radiology / Issue 9/2016
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-016-0769-9

Other articles of this Issue 9/2016

Abdominal Radiology 9/2016 Go to the issue

Classics in Abdominal Imaging

Milk of calcium bile

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.